These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18339647)

  • 1. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.
    Buys ES; Sips P; Vermeersch P; Raher MJ; Rogge E; Ichinose F; Dewerchin M; Bloch KD; Janssens S; Brouckaert P
    Cardiovasc Res; 2008 Jul; 79(1):179-86. PubMed ID: 18339647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
    De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA; Antunes E; Teixeira CE; De Nucci G
    Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE.
    Dordea AC; Vandenwijngaert S; Garcia V; Tainsh RE; Nathan DI; Allen K; Raher MJ; Tainsh LT; Zhang F; Lieb WS; Mikelman S; Kirby A; Stevens C; Thoonen R; Hindle AG; Sips PY; Falck JR; Daly MJ; Brouckaert P; Bloch KD; Bloch DB; Malhotra R; Schwartzman ML; Buys ES
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1790-800. PubMed ID: 27199131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.
    Cai C; Chen SY; Zheng Z; Omwancha J; Lin MF; Balk SP; Shemshedini L
    Oncogene; 2007 Mar; 26(11):1606-15. PubMed ID: 16964290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
    J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.
    Groneberg D; König P; Wirth A; Offermanns S; Koesling D; Friebe A
    Circulation; 2010 Jan; 121(3):401-9. PubMed ID: 20065162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
    Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
    Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells.
    Wen HC; Chuu CP; Chen CY; Shiah SG; Kung HJ; King KL; Su LC; Chang SC; Chang CH
    PLoS One; 2015; 10(4):e0125518. PubMed ID: 25928539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation.
    Kajiya K; Huggenberger R; Drinnenberg I; Ma B; Detmar M
    FASEB J; 2008 Feb; 22(2):530-7. PubMed ID: 17855621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells.
    Borges de Oliveira-Junior E; Thomazzi SM; Rehder J; Antunes E; Condino-Neto A
    Eur J Pharmacol; 2007 Jul; 567(1-2):43-9. PubMed ID: 17499238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.
    Buys ES; Raher MJ; Kirby A; Shahid M; Baron DM; Hayton SR; Tainsh LT; Sips PY; Rauwerdink KM; Yan Q; Tainsh RE; Shakartzi HR; Stevens C; Decaluwé K; Rodrigues-Machado Mda G; Malhotra R; Van de Voorde J; Wang T; Brouckaert P; Daly MJ; Bloch KD
    J Clin Invest; 2012 Jun; 122(6):2316-25. PubMed ID: 22565307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
    Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.